tiprankstipranks
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
US Market
Holding ZBIO?
Track your performance easily

Zenas BioPharma, Inc. (ZBIO) Income Statement

2 Followers

Zenas BioPharma, Inc. Income Statement

Last quarter (Q ), Zenas BioPharma, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q, Zenas BioPharma, Inc.'s net income was $-37.98M. See Zenas BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
$ 50.00M
Cost of Revenue
-
Gross Profit
$ 50.00M
Operating Expense
$ 87.15M
Operating Income
$ -37.15M
Net Non Operating Interest Income Expense
-
Other Income Expense
$ -324.00K
Pretax Income
$ -36.82M
Tax Provision
$ 301.00K
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -37.12M
Basic EPS
-
Diluted EPS
-
Basic Average Shares
$ 13.30M
Diluted Average Shares
$ 13.30M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 87.15M
Net Income From Continuing And Discontinued Operation
$ -37.12M
Normalized Income
$ -27.06M
Interest Expense
-
EBIT
$ -36.82M
EBITDA
$ -36.71M
Currency in USD

Zenas BioPharma, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis